Stem-Cell Clinical Trials Move Debate Beyond Labs

Professor Pete Coffey (UCL Institute of Ophthalmology), in collaboration with Pfizer, is awaiting regulatory permission to begin an embryonic stem cell trial to treat age-related macular degeneration.